{"schema_version":"1","generated_at":"2026-11-01T14:30:38.926Z","data_as_of":null,"url":"https://www.findmykol.com/kol/thanh-dellinger","json_url":"https://www.findmykol.com/kol/thanh-dellinger/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"thanh-dellinger","name":"Thanh Dellinger","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"City Of Hope National Medical Center","institution_url":"https://www.findmykol.com/institution/city-of-hope","city":"Duarte","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1073730891","orcid":"0000-0003-1855-1989","openalex":"A5047237088"},"summary":"Thanh Dellinger is an Oncology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 177 publications with 2,045 citations (h-index 27); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":177,"cited_by_count":2045,"h_index":27,"latest_activity_year":2025,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04329494","title":"PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT04329494","trial_url":"https://www.findmykol.com/trial/NCT04329494"},{"nct":"NCT03671811","title":"Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT03671811","trial_url":"https://www.findmykol.com/trial/NCT03671811"},{"nct":"NCT03113487","title":"P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT03113487","trial_url":"https://www.findmykol.com/trial/NCT03113487"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"INTUITIVE SURGICAL, INC.","program_year":2025,"amount_usd":162.65,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1073730891"},{"payer":"Tempus AI, Inc","program_year":2024,"amount_usd":85.45,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1073730891"},{"payer":"Eisai Inc.","program_year":2024,"amount_usd":19.18,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1073730891"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1073730891","source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":100,"drugs":[{"name":"Oxycodone-Acetaminophen","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":24.1,"facility_pct":75.9},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus","year":2025,"journal":"British journal of surgery","source_url":"https://doi.org/10.1093/bjs/znaf112","status":"verified"},{"title":"A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer","year":2024,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2023.12.017","status":"verified"},{"title":"Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial","year":2024,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-024-15980-9","status":"verified"},{"title":"Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA","year":2023,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-023-13941-2","status":"verified"},{"title":"Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer","year":2023,"journal":"Journal of Ovarian Research","source_url":"https://doi.org/10.1186/s13048-023-01234-x","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 DUARTE RD","address_2":"MOB 1002B","city":"Duarte","state":"CA","zip":"910103012","phone":"626-471-9353","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1073730891","source":"identity"},"similar":[{"name":"Erminia Massarelli","slug":"erminia-massarelli","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/erminia-massarelli","json_url":"https://www.findmykol.com/kol/erminia-massarelli/profile.json"},{"name":"Swetha Thiruvengadam","slug":"swetha-thiruvengadam","institution":"City Of Hope National Medical Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/swetha-thiruvengadam","json_url":"https://www.findmykol.com/kol/swetha-thiruvengadam/profile.json"},{"name":"Yuman Fong","slug":"yuman-fong","institution":"City Of Hope National Medical Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/yuman-fong","json_url":"https://www.findmykol.com/kol/yuman-fong/profile.json"},{"name":"Ravi Salgia","slug":"ravi-salgia","institution":"City Of Hope National Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ravi-salgia","json_url":"https://www.findmykol.com/kol/ravi-salgia/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-02-09","provider_certified":"2021-02-09","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}